Vol. 1 No. 2 (2024), Articles
Vol. 1 No. 2 (2024)

WHAT'S NEW ABOUT THE THYROID GLAND AND AGING?

Articles
Published 2024-11-08
Zokirjonov Diyorbek Zafarjon o‘g‘li
Farg‘ona jamoat salomatligi tibbiyot instituti “Patologik fiziologiya va patologik anatomiya” kafedrasi assistenti.
Alimov Farrux Farhodovich
Farg‘ona jamoat salomatligi tibbiyot instituti “Xalq tabobati va farmakologiya” kafedrasi assistenti.
PDF

Keywords

Aging, subclinical thyroid malfunction, thyroid cancer, longevity, and thyroid gland

Abstract

As people age, significant functional changes occur in the endocrine system and specific endocrine organs, such as the thyroid. Thyroid diseases are more common as people age, and it is well known that the thyroid gland undergoes a number of morphological and physiological changes as people age. It should be emphasized that the clinical course of thyroid problems in the elderly is fundamentally different from that seen in younger people since the symptoms are more subdued and frequently mistaken for the signs of aging. In older people, additional care is needed for thyroid neoplasms and subclinical hypo- and hyperthyroidism. Interestingly, a longer lifespan may be attributed to both diminished thyroid function and thyrotropin (TSH) levels, which gradually increase with age.  Recent research on the changes in thyroid function with age, including those that might result in longer lifespans in both people and animals, is the main topic of this brief overview.

PDF

References

1. Lewiński A, Sewerynek E, Karbownik M: Aging processes and the thyroid gland. In Aging and Age-Related Diseases: The Basics. Edited by Karasek M. New York: Nova Science Publishers, Inc; 2006:131–172.

2. Faggiano A, Del Prete M, Marciello F, Marotta V, Ramundo V, Colao A:

Thyroid diseases in elderly. Minerva Endocrinol 2011, 36:211–231.

3. Papaleontiou M, Haymart MR: Approach to and treatment of thyroid disorders in the elderly. Med Clin North Am 2012, 96:297–310.

4. Cooper DS: Thyroid disease in the oldest old: the exception to the rule. JAMA 2004, 292:2651–2654.

5. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291:228–238.

6. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N: Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008, 148:832–845.

7. Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I: Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009, 94:1251–1254.

8. Boucai L, Surks MI: Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol 2009, 70:788–793.

9. Surks MI, Boucai L: Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010, 95:496–502.

10. Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O’Leary PC, Walsh JP: Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012, 97:1554–1562.

11. Cooper DS, Biondi B: Subclinical thyroid disease. Lancet 2012,

379:1142–1154.

12. Yeap BB: Hormones and health outcomes in aging men. Exp Gerontol

2012, in press, http://dx.doi.org/10.1016/j.exger.2012.07.012.

13. Biondi B, Cooper DS: The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29:76–131.

14. Kramer C, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E: Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study. Eur J Endocrinol 2009, 161:917–921.

15. de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijs HC, Kramer MH, Vandenbroucke JP, Dekkers OM: Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 2011, 165:545–554.

16. Park YJ, Lee EJ, Lee YJ, Choi SH, Park JH, Lee SB, Lim S, Lee WW, Jang HC, Cho BY, Woo JI, Kim KW: Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch Gerontol Geriatr 2010, 50:e68–e73.

17. Begin ME, Langlois MF, Lorrain D, Cunnane SC: Thyroid function and cognition during aging. Curr Gerontol Geriatr Res 2008, doi:10.1155/2008/ 474868.

18. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J, Thyroid Studies Collaboration: Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010, 304:1365–1374.

19. Bensenor IM, Olmos RD, Lotufo PA: Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging 2012, 7:97–111.

20. Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, Heath C, Sheppard M, Franklyn J, Hobbs FD: A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community- living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab 2010, 95:3623–3632.

21. Somwaru LL, Rariy CM, Arnold AM, Cappola AR: The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012, 97:1962–1969.

22. Imaizumi M, Sera N, Ueki I, Horie I, Ando T, Usa T, Ichimaru S, Nakashima E, Hida A, Soda M, Tominaga T, Ashizawa K, Maeda R, Nagataki S, Akahoshi M: Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism. Thyroid 2011,21:1177–1182.

23. Ceresini G, Lauretani F, Maggio M, Ceda GP, Morganti S, Usberti E, Chezzi C, Valcavi R, Bandinelli S, Guralnik JM, Cappola AR, Valenti G, Ferrucci L: Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc 2009, 57:89–93.

24. Turner MR, Camacho X, Fischer HD, Austin PC, Anderson GM, Rochon PA, Lipscombe LL: Levothyroxine dose and risk of fractures in older adults: nested case–control study. BMJ 2011, 342:d2238.

25. Mitrou P, Raptis SA, Dimitriadis G: Thyroid disease in older people.

Maturitas 2011, 70:5–9.

26. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Mollinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N, Thyroid Studies Collaboration: Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012, 172:799–809.

27. Rosario PW: Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study. Clin Endocrinol 2010, 72:685–688.

28. Suzuki S, Nishio S, Takeda T, Komatsu M: Gender-specific regulation of response to thyroid hormone in aging. Thyroid Res 2012, 5:1.

29. Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR: Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of non-vertebral.

30. Mariotti S, Franceschi C, Cossarizza A, Pinchera A: The aging thyroid. Endocr Rev 1995, 16:686–715.

31. Chahal HS, Drake WM: The endocrine system and ageing. J Pathol 2007,

211:173–180.

32. Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, Magri F: Neuroendocrine features in extreme longevity. Exp Gerontol 2008, 43:88–94.

33. Sell MA, Schott M, Tharandt L, Cissewski K, Scherbaum WA, Willenberg HS: Functional central hypothyroidism in the elderly. Aging Clin Exp Res 2008, 20:207–210.

34. Mazzoccoli G, Pazienza V, Piepoli A, Muscarella LA, Inglese M, De Cata A, Giuliani F, Tarquini R: Hypothalamus-hypophysis-thyroid axis function in healthy aging. J Biol Regul Homeost Agents 2010, 24:433–439.

35. Over R, Mannan S, Nsouli-Marktabi H, Burman KD, Jonklaas J: Age and the thyrotropin response to hypothyroxinemia. J Clin Endocrinol Metab 2010, 95:3675–3683.

36. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87:489–499.

37. Atzmon G, Barzilai N, Surks MI, Gabriely I: Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab 2009, 94:4768–4775.

38. Rozing MP, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Frölich M, de Craen AJ, Westendorp RG, van Heemst D: Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab 2010, 95:4979–4984.

39. Corsonello A, Montesanto A, Berardelli M, De Rango F, Dato S, Mari V,

Mazzei B, Lattanzio F, Passarino G: A cross-section analysis of FT3

age-related changes in a group of old and oldest-old subjects, including centenarians’ relatives, shows that a down-regulated thyroid function has a familial component and is related to longevity. Age Ageing 2010, 39:723–727.

40. Brown-Borg HM: Hormonal regulation of longevity in mammals. Ageing Res Rev 2007, 6:28–45.

41. Buffenstein R, Pinto M: Endocrine function in naturally long-living small mammals. Mol Cell Endocrinol 2009, 299:101–111.

42. Edrey YH, Park TJ, Kang H, Biney A, Buffenstein R: Endocrine function and neurobiology of the longest-living rodent, the naked mole-rat.

Exp Gerontol 2011, 46:116–123.

43. Gesing A, Bartke A, Masternak MM, Lewiński A, Karbownik-Lewińska M: Decreased thyroid follicle size in dwarf mice may suggest the role of growth hormone signaling in thyroid growth regulation. Thyroid Res 2012, 5.

44. Rukhman N, Silverberg A: Thyroid cancer in older men. Aging Male 2011,

14:91–98.

45. Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, Anderson WF: Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009, 18:1092–1100.

46. Toniato A, Bernardi C, Piotto A, Rubello D, Pelizzo MR: Features of papillary thyroid carcinoma in patients older than 75 years. Updates Surg 2011, 63:115–118.

47. Chrisoulidou A, Boudina M, Tzemailas A, Doumala E, Iliadou PK, Patakiouta F, Pazaitou-Panayiotou K: Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer. Thyroid Res 2011, 4:12.

48. Mordalska A, Latek J, Ferenc T, Pomorski L, Gałecka E, Zygmunt A, Lewinski

A: Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes. Thyroid Res 2010, 3:6.

49. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A: Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 2007, 31:2085–2091.

50. Habra M, Sarlis NJ: Thyroid and aging. Rev Endocr Metab Disord 2005,

6:145–154.